WeChat Mini Program
Old Version Features

Translational PK/PD and the First-in-human Dose Selection of a PD1/IL15: an Engineered Recombinant Targeted Cytokine for Cancer Immunotherapy

Rajbharan Yadav,Suzanne Schubbert,Patrick G. Holder,Eugene Y. Chiang, Nargess Kiabi,Liz Bogaert,Irene Leung,Rumana Rashid,Kendra N. Avery,Christine Bonzon,John R. Desjarlais,Shomyseh Sanjabi,Amy Sharma,Michelle Lepherd,Amy Shelton, Pam Chan,Yanqiu Liu,Louis Joslyn,Iraj Hosseini,Eric G. Stefanich,Amrita V. Kamath,Matthew J. Bernett,Vittal Shivva

Frontiers in Pharmacology（2024）

Cited 0|Views16
Key words
targeted cytokine,PD1/IL15 TaCK,minimum anticipated biological effect level,first-in-human dose,target mediated drug disposition
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined